Cargando…
The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias
Acute leukemia is the most common type of childhood and adolescence cancer, characterized by clonal proliferation of variably differentiated myeloid or lymphoid precursors. Recent insights into the molecular pathogenesis of leukemia have shown that epigenetic modifications, such as deacetylation of...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026992/ https://www.ncbi.nlm.nih.gov/pubmed/21318168 http://dx.doi.org/10.1155/2011/148046 |
_version_ | 1782197110680059904 |
---|---|
author | Masetti, Riccardo Serravalle, Salvatore Biagi, Carlotta Pession, Andrea |
author_facet | Masetti, Riccardo Serravalle, Salvatore Biagi, Carlotta Pession, Andrea |
author_sort | Masetti, Riccardo |
collection | PubMed |
description | Acute leukemia is the most common type of childhood and adolescence cancer, characterized by clonal proliferation of variably differentiated myeloid or lymphoid precursors. Recent insights into the molecular pathogenesis of leukemia have shown that epigenetic modifications, such as deacetylation of histones and DNA methylation, play crucial roles in leukemogenesis, by transcriptional silencing of critical genes. Histone deacetylases (HDACs) are potential targets in the treatment of leukaemia, and, as a consequence, inhibitors of HDACs (HDIs) are being studied for therapeutic purposes. HDIs promote or enhance several different anticancer mechanisms, such as apoptosis, cell cycle arrest, and cellular differentiation and, therefore, are in evidence as promising treatment for children and adolescents with acute leukemia, in monotherapy or in association with other anticancer drugs. Here we review the main preclinical and clinical studies regarding the use of HDIs in treating childhood and adolescence leukemia. |
format | Text |
id | pubmed-3026992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30269922011-02-11 The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias Masetti, Riccardo Serravalle, Salvatore Biagi, Carlotta Pession, Andrea J Biomed Biotechnol Review Article Acute leukemia is the most common type of childhood and adolescence cancer, characterized by clonal proliferation of variably differentiated myeloid or lymphoid precursors. Recent insights into the molecular pathogenesis of leukemia have shown that epigenetic modifications, such as deacetylation of histones and DNA methylation, play crucial roles in leukemogenesis, by transcriptional silencing of critical genes. Histone deacetylases (HDACs) are potential targets in the treatment of leukaemia, and, as a consequence, inhibitors of HDACs (HDIs) are being studied for therapeutic purposes. HDIs promote or enhance several different anticancer mechanisms, such as apoptosis, cell cycle arrest, and cellular differentiation and, therefore, are in evidence as promising treatment for children and adolescents with acute leukemia, in monotherapy or in association with other anticancer drugs. Here we review the main preclinical and clinical studies regarding the use of HDIs in treating childhood and adolescence leukemia. Hindawi Publishing Corporation 2011 2011-01-13 /pmc/articles/PMC3026992/ /pubmed/21318168 http://dx.doi.org/10.1155/2011/148046 Text en Copyright © 2011 Riccardo Masetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Masetti, Riccardo Serravalle, Salvatore Biagi, Carlotta Pession, Andrea The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias |
title | The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias |
title_full | The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias |
title_fullStr | The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias |
title_full_unstemmed | The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias |
title_short | The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias |
title_sort | role of hdacs inhibitors in childhood and adolescence acute
leukemias |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026992/ https://www.ncbi.nlm.nih.gov/pubmed/21318168 http://dx.doi.org/10.1155/2011/148046 |
work_keys_str_mv | AT masettiriccardo theroleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT serravallesalvatore theroleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT biagicarlotta theroleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT pessionandrea theroleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT masettiriccardo roleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT serravallesalvatore roleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT biagicarlotta roleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias AT pessionandrea roleofhdacsinhibitorsinchildhoodandadolescenceacuteleukemias |